Buscar
01/12/2021
Clinical triage of patients on kidney replacement therapy presenting with COVID-19: an ERACODA registry analysis
Mitra, S, Jayanti, A, Vart, P, Coca, A, Gallieni, M, Ovrehus, MA, Midtvedt, K, Abd ElHafeez, S, Gandolfini, I, Buttner, S, Franssen, CFM, Hemmelder, MH, Canal C., Facundo C., ERACODA Collaborators. Clinical triage of patients on kidney replacement therapy presenting with COVID-19: an ERACODA registry analysis. NEPHROLOGY DIALYSIS TRANSPLANTATION. 2021; 36(12)DOI:10.1093/ndt/gfab196. PMID:34129039. IF:7.186(Q1/2D).
01/12/2021
Eculizumab in refractory generalized myasthenia gravis previously treated with rituximab: subgroup analysis of REGAIN and its extension study
Siddiqi, ZA, Nowak, RJ, Mozaffar, T, O'Brien, F, Yountz, M, Patti, F, Illa I., Cortés-Vicente E., Díaz-Manera J., Querol L.A., Rojas-García R., Vidal-Fernandez N., Nye, Joan L.. Eculizumab in refractory generalized myasthenia gravis previously treated with rituximab: subgroup analysis of REGAIN and its extension study. MUSCLE & NERVE. 2021; 64(6)DOI:10.1002/mus.27422. PMID:34590717. IF:3.852(Q2/5D).
01/12/2021
Rationale and Design of the Efficacy of a Standardized Diuretic Protocol in Acute Heart Failure Study
Dauw, J, Lelonek, M, Zegri-Reiriz, I, Paredes-Paucar, CP, Zara, C, George, V, Cobo-Marcos, M, Knappe, D, Shchekochikhin, D, Lekhakul, A, Klincheva, M, Frea, S, Miro, O, Barker, D, Borbely, A, Nasr, S, Doghmi, N, de la Espriella, R, Singh, JS, Bovolo, V, Fialho, I, Ross, NT, van den Heuvel, M, Benkouar, R, Findeisen, H, Alhaddad, IA, Al Balbissi, K, Barge-Caballero, G, Ghazi, AM, Bruckers, L, Martens, P, Mullens, W. Rationale and Design of the Efficacy of a Standardized Diuretic Protocol in Acute Heart Failure Study. ESC Heart Failure. 2021; 8(6)DOI:10.1002/ehf2.13666. PMID:34708555. IF:3.612(Q2/5D).
01/12/2021
Multi-Centre, Multi-Vendor and Multi-Disease Cardiac Segmentation: The M&Ms Challenge
Campello, VM, Gkontra, P, Izquierdo, C, Martin-Isla, C, Sojoudi, A, Full, PM, Maier-Hein, K, Zhang, Y, He, ZQ, Ma, J, Parreno, M, Albiol, A, Kong, FW, Shadden, SC, Acero, JC, Sundaresan, V, Saber, M, Elattar, M, Li, HW, Menze, B, Khader, F, Haarburger, C, Scannell, CM, Veta, M, Carscadden, A, Punithakumar, K, Liu, X, Tsaftaris, SA, Huang, XQ, Yang, X, Li, L, Zhuang, XH, Vilades, D, Descalzo, ML, Guala, A, La Mura, L, Friedrich, MG, Garg, R, Lebel, J, Henriques, F, Karakas, M, Cavus, E, Petersen, SE, Escalera, S, Segui, S, Rodriguez-Palomares, JF, Lekadir, K. Multi-Centre, Multi-Vendor and Multi-Disease Cardiac Segmentation: The M&Ms Challenge. IEEE TRANSACTIONS ON MEDICAL IMAGING. 2021; 40(12)DOI:10.1109/TMI.2021.3090082. PMID:34138702. IF:11.037(Q1/1D).
01/12/2021
Worldwide sedation strategies for atrial fibrillation ablation: current status and evolution over the last decade
Garcia, R, Waldmann, V, Vanduynhoven, P, Nesti, M, Figueiredo, MJD, Narayanan, K, Conte, G, Guerra, JM, Boveda, S, Duncker, D. Worldwide sedation strategies for atrial fibrillation ablation: current status and evolution over the last decade. EUROPACE. 2021; 23(12)DOI:10.1093/europace/euab154. PMID:34308973. IF:5.486(Q2/4D).
01/12/2021
Prevalence, mechanisms and impact of residual patency and device-related thrombosis following left atrial appendage occlusion: a computed tomography analysis
Agudelo, V, Millan, X, Li, CH, Moustafa, AH, Asmarats, L, Serra, A, Arzamendi, D. Prevalence, mechanisms and impact of residual patency and device-related thrombosis following left atrial appendage occlusion: a computed tomography analysis. EuroIntervention. 2021; 17(11)DOI:10.4244/EIJ-D-21-00320. PMID:34219668. IF:7.728(Q1/2D).
01/12/2021
ICD shock below the detection rate therapy zone-When appropriate is inadequate
Garcia-Hernando, V, Mendez-Zurita, F, Rodriguez-Font, E, Alonso-Martin, C, Guerra-Ramos, JM, Campos-Garcia, B, Moreno-Weidmann, Z, Benedicto, AM, Vinolas, X. ICD shock below the detection rate therapy zone-When appropriate is inadequate. JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY. 2021; 32(12)DOI:10.1111/jce.15241. PMID:34532919. IF:2.942(Q3/6D).
01/12/2021
Dyslipidemia and aortic valve disease
Mata, P, Alonso, R, de Isla, LP, Badimon, L. Dyslipidemia and aortic valve disease. CURRENT OPINION IN LIPIDOLOGY. 2021; 32(6)DOI:10.1097/MOL.0000000000000794. PMID:34629429. IF:4.616(Q2/4D).
01/12/2021
One year of omega 3 polyunsaturated fatty acid supplementation does not reduce circulating prothrombotic microvesicles in elderly subjects after suffering a myocardial infarction
Chiva-Blanch, G, Bratseth, V, Laake, K, Arnesen, H, Solheim, S, Schmidt, EB, Badimon, L, Seljeflot, I. One year of omega 3 polyunsaturated fatty acid supplementation does not reduce circulating prothrombotic microvesicles in elderly subjects after suffering a myocardial infarction. CLINICAL NUTRITION. 2021; 40(12)DOI:10.1016/j.clnu.2021.10.007. PMID:34742136. IF:7.643(Q1/2D).
01/12/2021
Current Status of Genetic Counselling for Rare Diseases in Spain
Alvaro-Sanchez, S, Abreu-Rodriguez, I, Abuli, A, Serra-Juhe, C, Garrido-Navas, MD. Current Status of Genetic Counselling for Rare Diseases in Spain. Diagnostics. 2021; 11(12)DOI:10.3390/diagnostics11122320. PMID:34943558. IF:3.992(Q2/4D).
01/12/2021
Immunoparesis defined by heavy/light chain pair suppression in smoldering multiple myeloma shows initial isotype specificity and involves other isotypes in advanced disease
Isola, I, Moreno, DF, Moga, E, Mena, MP, Tovar, N, Rodriguez-Lobato, LG, Oliver-Caldes, A, Salgado, MC, Braso-Maristany, F, Yague, J, Cibeira, MT, Prat, A, Rosinol, L, Blade, J, de Larrea, CF. Immunoparesis defined by heavy/light chain pair suppression in smoldering multiple myeloma shows initial isotype specificity and involves other isotypes in advanced disease. ANNALS OF HEMATOLOGY. 2021; 100(12)DOI:10.1007/s00277-021-04653-2. PMID:34463804. IF:4.030(Q2/5D).
01/12/2021
Extracellular Vesicles in Pulmonary Fibrosis Models and Biological Fluids of Interstitial Lung Disease Patients: A Scoping Review
d'Alessandro, M, Bergantini, L, Bargagli, E, Vidal, S. Extracellular Vesicles in Pulmonary Fibrosis Models and Biological Fluids of Interstitial Lung Disease Patients: A Scoping Review. Life-Basel. 2021; 11(12)DOI:10.3390/life11121401. PMID:34947932. IF:3.253(Q2/5D).
01/12/2021
Characterization of the hypertriglyceridemic waist phenotype in patients with type 2 diabetes mellitus in Spain: an epidemiological study
Minambres, I, Sanchez-Hernandez, J, Cuixart, G, Sanchez-Pinto, A, Sarroca, J, Perez, A. Characterization of the hypertriglyceridemic waist phenotype in patients with type 2 diabetes mellitus in Spain: an epidemiological study. REVISTA CLINICA ESPANOLA. 2021; 221(10)DOI:10.1016/j.rce.2020.06.013. PMID:34839890. IF:3.064(Q2/5D).
01/12/2021
Therapeutic Potential of Emerging NAD plus -Increasing Strategies for Cardiovascular Diseases
Rotllan, N, Camacho, M, Tondo, M, Diarte-Anazco, EMG, Canyelles, M, Mendez-Lara, KA, Benitez, S, Alonso, N, Mauricio, D, Escola-Gil, JC, Blanco-Vaca, F, Julve, J. Therapeutic Potential of Emerging NAD plus -Increasing Strategies for Cardiovascular Diseases. Antioxidants. 2021; 10(12)DOI:10.3390/antiox10121939. PMID:. IF:7.675(Q1/1D).
01/12/2021
Advanced Quantitative Lipoprotein Characteristics Do Not Relate to Healthy Dietary Patterns in Adults from a Mediterranean Area
Rojo-Lopez, MI, Castelblanco, E, Real, J, Hernandez, M, Falguera, M, Amigo, N, Julve, J, Alonso, N, Franch-Nadal, J, Granado-Casas, M, Mauricio, D. Advanced Quantitative Lipoprotein Characteristics Do Not Relate to Healthy Dietary Patterns in Adults from a Mediterranean Area. Nutrients. 2021; 13(12)DOI:10.3390/nu13124369. PMID:34959921. IF:6.706(Q1/2D).
01/12/2021
Advanced lipoprotein parameters could better explain atheromatosis in non-diabetic chronic kidney disease patients
Bermudez-Lopez, M, Perpinan, H, Amigo, N, Castro, E, Alonso, N, Mauricio, D, Fernandez, E, Valdivielso, JM. Advanced lipoprotein parameters could better explain atheromatosis in non-diabetic chronic kidney disease patients. Clinical Kidney Journal. 2021; 14(12)DOI:10.1093/ckj/sfab113. PMID:34950470. IF:5.860(Q1/2D).
01/12/2021
Outstanding improvement of the advanced lipoprotein profile in subjects with new-onset type 1 diabetes mellitus after achieving optimal glycemic control
Castelblanco, E, Hernandez, M, Ortega, E, Amigo, N, Real, J, Granado-Casas, M, Minambres, I, Lopez, C, Lecube, A, Bermudez-Lopez, M, Alonso, N, Julve, J, Mauricio, D. Outstanding improvement of the advanced lipoprotein profile in subjects with new-onset type 1 diabetes mellitus after achieving optimal glycemic control. DIABETES RESEARCH AND CLINICAL PRACTICE. 2021; 182DOI:10.1016/j.diabres.2021.109145. PMID:34785302. IF:8.180(Q1/2D).
01/12/2021
Short-term foot complications in Charcot neuroarthropathy: A retrospective study in tertiary care centres in tertiary care centres in Spain (vol 65, pg 479, 2018)
Doria, M, Viade, J, Palomera, E, Perez, R, Llado, M, Costa, E, Huguet, T, Reverter, JL, Serra-Prat, M, Franch-Nadal, J, Mauricio, D. Short-term foot complications in Charcot neuroarthropathy: A retrospective study in tertiary care centres in tertiary care centres in Spain (vol 65, pg 479, 2018). Endocrinologia Diabetes y Nutricion. 2021; 68(10)DOI:10.1016/j.endinu.2021.10.002. PMID:. IF:1.833(Q4/9D).
01/12/2021
Incidence and characteristics of diabetic foot ulcers in subjects with type 2 diabetes in Catalonian primary care centres: An observational multicentre study
Bundo, M, Llussa, J, Serra, M, de la Iglesia, PP, Gimbert, RM, Real, J, Vlacho, B, Mata-Cases, M, Cos, X, Franch-Nadal, J, Mauricio, D. Incidence and characteristics of diabetic foot ulcers in subjects with type 2 diabetes in Catalonian primary care centres: An observational multicentre study. Primary Care Diabetes. 2021; 15(6)DOI:10.1016/j.pcd.2021.08.002. PMID:34419365. IF:2.567(Q3/6D).
01/12/2021
Resistance to first-generation somatostatin receptor ligands does not impair the results of gamma knife radiosurgery in acromegaly
Losa, M, Resmini, E, Barzaghi, LR, Albano, L, Bailo, M, Webb, SM, Mortini, P. Resistance to first-generation somatostatin receptor ligands does not impair the results of gamma knife radiosurgery in acromegaly. CLINICAL ENDOCRINOLOGY. 2021; 95(6)DOI:10.1111/cen.14547. PMID:34219264. IF:3.523(Q3/7D).
01/12/2021
Consensus on diagnosis and management of Cushing's disease: a guideline update
Fleseriu, M, Auchus, R, Bancos, I, Ben-Shlomo, A, Bertherat, J, Biermasz, NR, Boguszewski, CL, Bronstein, MD, Buchfelder, M, Carmichael, JD, Casanueva, FF, Castinetti, F, Chanson, P, Findling, J, Gadelha, M, Geer, EB, Giustina, A, Grossman, A, Gurnell, M, Ho, K, Ioachimescu, AG, Kaiser, UB, Karavitaki, N, Katznelson, L, Kelly, DF, Lacroix, A, McCormack, A, Melmed, S, Molitch, M, Mortini, P, Newell-Price, J, Nieman, L, Pereira, AM, Petersenn, S, Pivonello, R, Raff, H, Reincke, M, Salvatori, R, Scaroni, C, Shimon, I, Stratakis, CA, Swearingen, B, Tabarin, A, Takahashi, Y, Theodoropoulou, M, Tsagarakis, S, Valassi, E, Varlamov, EV, Vila, G, Wass, J, Webb, SM, Zatelli, MC, Biller, BMK. Consensus on diagnosis and management of Cushing's disease: a guideline update. Lancet Diabetes & Endocrinology. 2021; 9(12)DOI:10.1016/S2213-8587(21)00235-7. PMID:34687601. IF:44.867(Q1/1D).
01/12/2021
Serum miR-181b-5p predicts ascites onset in patients with compensated cirrhosis
de Paredes, AGG, Villanueva, C, Blanco, C, Genesca, J, Manicardi, N, Garcia-Pagan, JC, Calleja, JL, Aracil, C, Morillas, RM, Poca, M, Penas, B, Augustin, S, Abraldes, JG, Alvarado, E, Royo, F, Garcia-Bermejo, ML, Falcon-Perez, JM, Banares, R, Bosch, J, Gracia-Sancho, J, Albillos, A. Serum miR-181b-5p predicts ascites onset in patients with compensated cirrhosis. Jhep Reports. 2021; 3(6)DOI:10.1016/j.jhepr.2021.100368. PMID:34712934. IF:9.917(Q1/2D).
01/12/2021
A Large Multicenter Prospective Study of Community-Onset Healthcare Associated Bacteremic Urinary Tract Infections in the Era of Multidrug Resistance: Even Worse than Hospital Acquired Infections?
Gomez-Zorrilla, S, Becerra-Aparicio, F, Montesinos, IL, de Gopegui, ER, Grau, I, Pintado, V, Padilla, B, Benito, N, Boix-Palop, L, Farinas, MC, Penaranda, M, Gamallo, MR, Martinez, JA, Morte-Romea, E, Del Pozo, JL, Duran-Jorda, X, Diaz-Reganon, J, Lopez-Mendoza, D, Canton, R, Oliver, A, Ruiz-Garbajosa, P, Horcajada, JP. A Large Multicenter Prospective Study of Community-Onset Healthcare Associated Bacteremic Urinary Tract Infections in the Era of Multidrug Resistance: Even Worse than Hospital Acquired Infections?. Infectious Diseases and Therapy. 2021; 10(4)DOI:10.1007/s40121-021-00537-0. PMID:34626347. IF:6.119(Q2/3D).
01/12/2021
Oral Antibiotic Prophylaxis Lowers Surgical Site Infection in Elective Colorectal Surgery: Results of a Pragmatic Cohort Study in Catalonia
Badia, JM, Flores-Yelamos, M, Vazquez, A, Arroyo-Garcia, N, Puig-Asensio, M, Pares, D, Pera, M, Lopez-Contreras, J, Limon, E, Pujol, M. Oral Antibiotic Prophylaxis Lowers Surgical Site Infection in Elective Colorectal Surgery: Results of a Pragmatic Cohort Study in Catalonia. Journal of Clinical Medicine. 2021; 10(23)DOI:10.3390/jcm10235636. PMID:34884337. IF:4.964(Q2/4D).
01/12/2021
How to Handle Concomitant Asymptomatic Prosthetic Joints During an Episode of Hematogenous Periprosthetic Joint Infection, a Multicenter Analysis
Wouthuyzen-Bakker, M, Sebillotte, M, Arvieux, C, Fernandez-Sampedro, M, Senneville, E, Barbero, JM, Lora-Tamayo, J, Aboltins, C, Trebse, R, Salles, MJ, Kramer, TS, Ferrari, M, Garcia-Canete, J, Benito, N, Diaz-Brito, V, Del Toro, MD, Scarborough, M, Soriano, A. How to Handle Concomitant Asymptomatic Prosthetic Joints During an Episode of Hematogenous Periprosthetic Joint Infection, a Multicenter Analysis. CLINICAL INFECTIOUS DISEASES. 2021; 73(11)DOI:10.1093/cid/ciaa1222. PMID:32813012. IF:20.999(Q1/1D).
01/12/2021
Identification of Recent Tuberculosis Exposure Using QuantiFERON-TB Gold Plus, a Multicenter Study
Perez-Recio, S, Pallares, N, Grijota-Camino, MD, Sanchez-Montalva, A, Barcia, L, Campos-Gutierrez, S, Pomar, V, Rabunal-Rey, R, Balcells, ME, Gazel, D, Montiel, N, Vicente, D, Goic-Barisic, I, Schon, T, Paues, J, Marekovic, I, Cacho-Calvo, J, Barac, A, Goletti, D, Garcia-Gasalla, M, Barcala, JM, Tortola, MT, Anibarro, L, Suarez-Toste, I, Moga, E, Gude-Gonzalez, MJ, Naves, R, Karsligil, T, Martin-Penaranda, T, Stevanovic, G, Trigo, M, Rubio, V, Karaoglan, I, Bayram, N, Alcaide, F, Tebe, C, Santin, M. Identification of Recent Tuberculosis Exposure Using QuantiFERON-TB Gold Plus, a Multicenter Study. Microbiology Spectrum. 2021; 9(3)DOI:10.1128/Spectrum.00972-21. PMID:34756079. IF:9.043(Q1/2D).
01/12/2021
Bronchial Thermoplasty Global Registry (BTGR): 2-year results
Torrego, A, Herth, FJ, Munoz-Fernandez, AM, Puente, L, Facciolongo, N, Bicknell, S, Novali, M, Gasparini, S, Bonifazi, M, Dheda, K, Andreo, F, Votruba, P, Langton, D, Flandes, J, Fielding, D, Bonta, PI, Skowasch, D, Schulz, C, Darwiche, K, McMullen, E, Grubb, GM, Niven, R. Bronchial Thermoplasty Global Registry (BTGR): 2-year results. BMJ Open. 2021; 11(12)DOI:10.1136/bmjopen-2021-053854. PMID:34916324. IF:3.007(Q2/5D).
01/12/2021
Alpha variant SARS-CoV-2 infection: How it all starts
Domingo, P, de Benito, N. Alpha variant SARS-CoV-2 infection: How it all starts. EBioMedicine. 2021; 74DOI:10.1016/j.ebiom.2021.103703. PMID:34800902. IF:11.205(Q1/2D).
01/12/2021
First-line osimertinib in patients with epidermal growth factor receptor-mutant non-small-cell lung cancer and with a coexisting low allelic fraction of Thr790Met
Majem, M, Sullivan, I, Viteri, S, Lopez-Vivanco, G, Cobo, M, Sanchez, JM, Garcia-Gonzalez, J, Garde, J, Sampayo, M, Martrat, G, Malfettone, A, Karachaliou, N, Molina-Vila, MA, Rosell, R. First-line osimertinib in patients with epidermal growth factor receptor-mutant non-small-cell lung cancer and with a coexisting low allelic fraction of Thr790Met. EUROPEAN JOURNAL OF CANCER. 2021; 159DOI:10.1016/j.ejca.2021.09.039. PMID:34763195. IF:10.002(Q1/2D).
01/12/2021
Effector Mechanisms of CD8+HLA-DR+ T Cells in Breast Cancer Patients Who Respond to Neoadjuvant Chemotherapy
Osuna-Gomez, R, Arqueros, C, Galano, C, Mulet, M, Zamora, C, Barnadas, A, Vidal, S. Effector Mechanisms of CD8+HLA-DR+ T Cells in Breast Cancer Patients Who Respond to Neoadjuvant Chemotherapy. Cancers. 2021; 13(24)DOI:10.3390/cancers13246167. PMID:34944786. IF:6.575(Q1/3D).
01/12/2021
PD-L1 testing and clinical management of newly diagnosed metastatic non-small cell lung cancer in Spain: MOREL study
Rubio-Viqueira, B, Tarruella, MM, Lazaro, M, Estevez, SV, Cordoba-Ortega, JF, Maiques, IM, Gonzalez, JG, Cordellat, AB, Valdivia-Bautista, J, Arenas, CG, Torres, JMS. PD-L1 testing and clinical management of newly diagnosed metastatic non-small cell lung cancer in Spain: MOREL study. Lung Cancer Management. 2021; 10(4)DOI:10.2217/lmt-2021-0008. PMID:34899993. IF:(Q/D).
01/12/2021
Management of Localized Muscle-Invasive Bladder Cancer from a Multidisciplinary Perspective: Current Position of the Spanish Oncology Genitourinary (SOGUG) Working Group
Caamano, AG, Vicente, AMGM, Maroto, P, Antolin, AR, Sanz, J, Gonzalez, MAV, Climent, MA. Management of Localized Muscle-Invasive Bladder Cancer from a Multidisciplinary Perspective: Current Position of the Spanish Oncology Genitourinary (SOGUG) Working Group. Current Oncology. 2021; 28(6)DOI:10.3390/curroncol28060428. PMID:34940067. IF:3.109(Q3/8D).
01/12/2021
Immunotherapy-induced isolated ACTH deficiency in cancer therapy
Iglesias, P, Peiro, I, Biagetti, B, Paja-Fano, M, Cobo, DA, Gomez, CG, Mateu-Salat, M, Genua, I, Majem, M, Riudavets, M, Gavira, J, Lamas, C, Pombo, AF, Guerrero-Perez, F, Villabona, C, Agricola, JMC, Webb, SM, Diez, JJ. Immunotherapy-induced isolated ACTH deficiency in cancer therapy. ENDOCRINE-RELATED CANCER. 2021; 28(12)DOI:10.1530/ERC-21-0228. PMID:34609950. IF:5.905(Q1/3D).
01/12/2021
Efficacy of nintedanib plus docetaxel in patients with refractory advanced epidermal growth factor receptor mutant lung adenocarcinoma
Riudavets, M, Bosch-Barrera, J, Cabezon-Gutierrez, L, Tain, PD, Hernandez, A, Alonso, M, Blanco, R, Galvez, E, Insa, A, Mielgo, X, Moran, T, Ponce, S, Roa, D, Sanchez, JM, Majem, M. Efficacy of nintedanib plus docetaxel in patients with refractory advanced epidermal growth factor receptor mutant lung adenocarcinoma. Clinical & Translational Oncology. 2021; 23(12)DOI:10.1007/s12094-021-02661-2. PMID:34292495. IF:3.340(Q3/7D).
01/12/2021
A DNA damage repair gene-associated signature predicts responses of patients with advanced soft-tissue sarcoma to treatment with trabectedin
Moura, DS, Pena-Chilet, M, Varela, JAC, Alvarez-Alegret, R, Agra-Pujol, C, Izquierdo, F, Ramos, R, Ortega-Medina, L, Martin-Davila, F, Castilla-Ramirez, C, Hernandez-Leon, CN, Romagosa, C, Salgado, MAV, Lavernia, J, Bague, S, Mayodormo-Aranda, E, Vicioso, L, Barcelo, JEH, Rubio-Casadevall, J, de Juan, A, Fiano-Valverde, MC, Hindi, N, Lopez-Alvarez, M, Lacerenza, S, Dopazo, J, Gutierrez, A, Alvarez, R, Valverde, C, Martinez-Trufero, J, Martin-Broto, J. A DNA damage repair gene-associated signature predicts responses of patients with advanced soft-tissue sarcoma to treatment with trabectedin. Molecular Oncology. 2021; 15(12)DOI:10.1002/1878-0261.12996. PMID:33983674. IF:7.449(Q1/3D).
01/12/2021
Predictive Value of MRP-1 in Localized High-Risk Soft Tissue Sarcomas: A Translational Research Associated to ISG-STS 1001 Randomized Phase III Trial
Martin-Broto, J, Lopez-Alvarez, M, Moura, DS, Ramos, R, Collini, P, Romagosa, C, Bague, S, Renne, SL, Barisella, M, Velasco, V, Coindre, JM, Lopez-Lopez, D, Dopazo, J, Gambarotti, M, Braglia, L, Merlo, DF, Palmerini, E, Stacchiotti, S, Quagliuolo, VL, Lopez-Pousa, A, Grignani, G, Blay, JY, Brunello, A, Gutierrez, A, Valverde, C, Hindi, N, Dei Tos, AP, Picci, P, Casali, PG, Gronchi, A. Predictive Value of MRP-1 in Localized High-Risk Soft Tissue Sarcomas: A Translational Research Associated to ISG-STS 1001 Randomized Phase III Trial. MOLECULAR CANCER THERAPEUTICS. 2021; 20(12)DOI:10.1158/1535-7163.MCT-21-0315. PMID:34552008. IF:6.011(Q2/3D).
01/12/2021
Predictive value of transcriptional expression of Kruppel-like factor-6 (KLF6) in head and neck carcinoma patients treated with radiotherapy
Leon, X, Venegas, M, Pujol, A, Bulboa, C, Llansana, A, Casasayas, M, Quer, M, Camacho, M. Predictive value of transcriptional expression of Kruppel-like factor-6 (KLF6) in head and neck carcinoma patients treated with radiotherapy. Clinical & Translational Oncology. 2021; 23(12)DOI:10.1007/s12094-021-02651-4. PMID:34061320. IF:3.340(Q3/7D).
01/12/2021
Timing of elective tracheotomy and duration of mechanical ventilation among patients admitted to intensive care with severe COVID-19: A multicenter prospective cohort study
Prats-Uribe, A, Tobed, M, Villacampa, JM, Aguero, A, Garcia-Bastida, C, Tato, JI, Rodriganez, L, Holguera, VD, Hernandez-Garcia, E, Poletti, D, Simonetti, G, Villarraga, V, Meler-Claramonte, C, Barrueco, AS, Chiesa-Estomba, C, Casasayas, M, Parente-Arias, P, Mata-Castro, N, Rello, J, Castro, P, Prieto-Alhambra, D, Vilaseca, I, Aviles-Jurado, FX. Timing of elective tracheotomy and duration of mechanical ventilation among patients admitted to intensive care with severe COVID-19: A multicenter prospective cohort study. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK. 2021; 43(12)DOI:10.1002/hed.26863. PMID:34524714. IF:3.821(Q1/2D).
01/12/2021
An adapted European LeukemiaNet genetic risk stratification for acute myeloid leukemia patients undergoing allogeneic hematopoietic cell transplant. A CIBMTR analysis
Jimenez, AMJ, De Lima, M, Komanduri, KV, Wang, TP, Zhang, MJ, Chen, KR, Abdel-Azim, H, Abid, MB, Aljurf, M, Alkhateeb, H, Assal, A, Bacher, U, Baron, F, Battiwalla, M, Beitinjaneh, A, Bejanyan, N, Bhatt, VR, Byrne, M, Cahn, JY, Cairo, M, Castillo, P, Copelan, E, DeFilipp, Z, Perez, MAD, Elsawy, M, Gale, RP, George, B, Grunwald, MR, Hildebrandt, GC, Hogan, WJ, Kanakry, CG, Kansagra, A, Kharfan-Dabaja, MA, Khera, N, Krem, MM, Lazaryan, A, Maakaron, J, Martino, R, McGuirk, J, Michelis, FV, Milone, G, Mishra, A, Murthy, HS, Mussetti, A, Nathan, S, Nishihori, T, Olsson, RF, Palmisiano, N, Patel, S, Saad, A, Seo, S, Sharma, A, Solh, M, Verdonck, LF, Wirk, B, Yared, JA, Litzow, M, Kebriaei, P, Hourigan, CS, Saber, W, Weisdorf, D. An adapted European LeukemiaNet genetic risk stratification for acute myeloid leukemia patients undergoing allogeneic hematopoietic cell transplant. A CIBMTR analysis. BONE MARROW TRANSPLANTATION. 2021; 56(12)DOI:10.1038/s41409-021-01450-3. PMID:34584240. IF:5.174(Q2/3D).
01/12/2021
Predictors of return to work after autologous stem cell transplantation in patients with multiple myeloma
Granell, M, Senin, A, Barata, A, Cibeira, MT, Gironella, M, Lopez-Pardo, J, Motllo, C, Garcia-Guinon, A, Ben-Azaiz, R, Abella, E, Soler, A, Canet, M, Marti, JM, Martino, R, Sierra, J, de Larrea, CF, Oriol, A, Rosinol, L. Predictors of return to work after autologous stem cell transplantation in patients with multiple myeloma. BONE MARROW TRANSPLANTATION. 2021; 56(12)DOI:10.1038/s41409-021-01429-0. PMID:34404917. IF:5.174(Q2/3D).